Results 211 to 220 of about 98,962 (385)

Switchable Intersystem Crossing (sISC) in Organic Dyes: Unlocking Dynamic Photonic Properties

ChemPhotoChem, EarlyView.
This Concept article introduces switchable intersystem crossing (sISC) as an emerging design strategy for functional dyes capable of reversibly modulating fluorescence and triplet state formation in response to environmental stimuli. Key design approaches and underlying mechanisms are discussed, alongside representative examples of sISC dyes and their ...
Mikhail A. Filatov, Metodej Dvoracek
wiley   +1 more source

Health biotechnology in China: National, regional, and sectoral dimensions [PDF]

Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies.
Conlé, Marcus
core  

Biopharmaceutical Studies of Drugs. III. Serum Concentration Level of o-Ethoxybenzamide and N-(β-Hydroxybutyryl)-p-phenetidine after Simultaneous Administration to Rabbit

, 1981
KAZUO KIGASAWA, M. HIIRAGI, Toshihiro Hayashi   +2 more
openalex   +2 more sources

A mammalian artificial chromosome engineering system (ACE System) applicable to biopharmaceutical protein production, transgenesis and gene-based cell therapy [PDF]

, 2004
Michael Lindenbaum, Ed Perkins, Erika Csonka, E. N. Fleming, Lisa Garcia, Amy L. Greene, Lindsay Gung, Gyula Hadlaczky, Edmond Lee, Josephine D. Leung, Neil MacDonald, Alexisann Maxwell, K. Mills, Diane Monteith, Carl F. Perez, Joan Shellard, Sandy J. Stewart, Tom Stodola, Dana Vandenborre, S. Vanderbyl, Harry C. Ledebur   +20 more
openalex   +1 more source

Re‐PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients

ESC Heart Failure, EarlyView.
Abstract Aims Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long‐acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family ...
Marcin Ufnal, Macarena P. Quintana‐Hayashi, Kathleen Connolly, Daniel Pettersen, Zsolt Cselényi, Aurelija Jucaite, Magnus Schou, Andrea Varrone, Melanie Chan, Lars H. Lund   +9 more
wiley   +1 more source

From Farming to "Pharming". Risks and Policy Challenges of Third Generation GM Crops [PDF]

Commercial and academic activities in the production of pharmaceuticals or other substances of industrial interests from genetically modified plants, i.e. molecular farming, have so far centred in the USA and Canada. Recent increases in EU activities and
Armin Spörk
core  

Biopharmaceutical Studies of Drugs. II. The Competitive Inhibition of Pentazocine Glucuronidation by Salicylamide in Vitro

, 1980
KAZUO KIGASAWA, Hiroaki Shimizu, Morihiro Saito, Toshihiro Hayashi   +3 more
openalex   +2 more sources

Galectin‐3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE‐TIMI 58

ESC Heart Failure, EarlyView.
Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller, Stephen D. Wiviott, David D. Berg, Petr Jarolim, Erica L. Goodrich, Deepak L. Bhatt, Ingrid Gause‐Nilsson, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Itamar Raz, Marc S. Sabatine, David A. Morrow   +12 more
wiley   +1 more source

Editorial: Proceedings of ISPMF 2018 - Plant Molecular Farming

Frontiers in Plant Science, 2020
Anneli Ritala, Heiko Rischer, Suvi Tuulikki Häkkinen, Jussi Joonas Joensuu, Kirsi-Marja Oksman-Caldentey   +4 more
doaj   +1 more source

Feasibility analysis of automated cleaning in biopharmaceutical production using cleaning-in-place concepts from food production. [PDF]

Front Med Technol
Groten F, Henze C, Joppa M, Herbst L, Nießing B, Mauermann M, Schmitt RH.   +6 more
europepmc   +1 more source